Proteomic approaches in drug discovery

Drug Discovery Today: Technologies

Volumn 3, Issue 4, 2006, Pages 433-440

  Veenstra, Timothy D ^a  

^a SAIC FREDERICK INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; IMATINIB; IMMUNOGLOBULIN; MEMBRANE RECEPTOR; PROTEIN CKAP4; UNCLASSIFIED DRUG; VIMENTIN;

CATION EXCHANGE; DRUG RESEARCH; DRUG TARGETING; GENETIC TRANSCRIPTION; HIGH THROUGHPUT SCREENING; HUMAN; INTERMETHOD COMPARISON; INTERSTITIAL CYSTITIS; ISOELECTRIC POINT; MASS SPECTROMETRY; METABOLITE; MOLECULAR WEIGHT; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN ANALYSIS; PROTEIN PHOSPHORYLATION; PROTEOMICS; REVERSED PHASE LIQUID CHROMATOGRAPHY; REVIEW; TWO DIMENSIONAL GEL ELECTROPHORESIS;

EID: 33846524839     PISSN: 17406749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ddtec.2006.10.001     Document Type: Review

References (17)

1. Hofstadler S.A., and Sannes-Lowery K.A. Application of ESI-MS in drug discovery: interrogation of noncovalent complexes. Nat. Rev. Drug Discov. 5 (2006) 585-595
2. Conrads T.P., et al. Sampling and analytical strategies for biomarker discovery using mass spectrometry. Biotechniques 40 (2006) 799-805
3. Pietrogrande M.C., et al. Decoding 2D-PAGE complex maps: relevance to proteomics. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 833 (2006) 51-62
4. Domon B., and Aebersold R.A. Mass spectrometry and protein analysis. Science 312 (2006) 212-217
5. Liu H., et al. Multidimensional separations for protein/peptide analysis in the post-genomic era. Biotechniques 32 (2002) 898-902
6. st century?. Nat. Rev. Drug Discov. 1 (2003) 309-315
7. Glenn J.S. Prenylation of HDAg and antiviral drug development. Curr. Top. Microbiol. Immunol. 307 (2006) 133-149
8. Abbosh P.H., et al. Dominant-negative histone H3 lysine 27 mutant derepresses silenced tumor suppressor genes and reverses the drug resistant phenotype in cancer cells. Cancer Res. 66 (2006) 5582-5591
9. Farzan M., et al. Tyrosine sulfation of the amino terminus of CCR5 facilitates HIV-1 entry. Cell 96 (1999) 667-676
10. Aggarwal K., et al. Shotgun proteomics using the iTRAQ isobaric tags. Brief. Funct. Genomic. Proteomic. 5 (2006) 112-120
11. Oh P., et al. Subtractive proteomic mapping of the endothelial surface in lung and solid tumour for tissue-specific therapy. Nature 429 (2004) 629-635
12. Conrads K.A., et al. A combined proteome and microarray investigation or inorganic phosphate-induced pre-osteoblast cells. Mol. Cell. Proteomics 4 (2005) 1284-1296
13. Vinarov D.A., and Markley J.L. High-throughput automated platform for nuclear magnetic resonance-based structure proteomics. Expert Rev. Proteomics 2 (2005) 49-55
14. Scapin G. Structural biology and drug discovery. Curr. Pharm. Des. 12 (2006) 2087-2097
15. Tugarinov V., et al. Nuclear magnetic resonance spectroscopy of high-molecular-weight proteins. Annu. Rev. Biochem. 73 (2004) 107-146
16. Keay S., et al. An antiproliferative factor from interstitial cystitis patients is a frizzled 8 protein-related sialoglycopeptide. Proc. Natl. Acad. Sci. U S A 101 (2004) 11803-11808
17. Conrads, T.P. et al. CKAP4/p63 is a receptor for the frizzled-8 protein-related antiproliferative factor from interstitial cystitis patients. J. Biol. Chem. (in press)